Clinical options for the reduction of elevated intraocular pressure
about
An emerging treatment option for glaucoma: Rho kinase inhibitorsDirect optic nerve sheath (DONS) application of Schwann cells prolongs retinal ganglion cell survival in vivoEpigenetic Modification Prevents Excessive Wound Healing and Scar Formation After Glaucoma Filtration Surgery.Effects of pre-surgical administration of prostaglandin analogs on the outcome of trabeculectomyRole of BDNF/TrkB pathway in the visual system: Therapeutic implications for glaucoma.
P2860
Clinical options for the reduction of elevated intraocular pressure
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Clinical options for the reduction of elevated intraocular pressure
@ast
Clinical options for the reduction of elevated intraocular pressure
@en
Clinical options for the reduction of elevated intraocular pressure
@nl
type
label
Clinical options for the reduction of elevated intraocular pressure
@ast
Clinical options for the reduction of elevated intraocular pressure
@en
Clinical options for the reduction of elevated intraocular pressure
@nl
prefLabel
Clinical options for the reduction of elevated intraocular pressure
@ast
Clinical options for the reduction of elevated intraocular pressure
@en
Clinical options for the reduction of elevated intraocular pressure
@nl
P2093
P2860
P356
P1476
Clinical options for the reduction of elevated intraocular pressure
@en
P2093
Laura Crawley
Maria F Cordeiro
Sohaib M Zamir
P2860
P356
10.4137/OED.S4909
P577
2012-04-30T00:00:00Z